Revolution in ophthalmology: Robot take over cataract operations!
Revolution in ophthalmology: Robot take over cataract operations!
In the world of medical technology, something is happening, and a company stands out: Forsight Robotics. The Israeli startup has recently completed a round of funding of $ 125 million, led by investors Eclipse Ventures, Adani Group and Reya Ventures. This totales the total financing to an impressive $ 195 million, and the company value is estimated at around $ 500 million. These headlines are only the start of an exciting journey into the future of ophthalmology.
The forensic dot Robotics mission is clear: they develop a unique assistance system for cataract surgery that is the first platform of its kind. Every year over 4 million cataract operations are carried out in the United States, and with a forecast decline in ophthalmologists by 12% by 2035, the chances are good that Forsweight will improve the urgently needed access to these interventions. The technology is tested on pig eyes, which in its nature behave similarly to human eyes, as the reports of Forbes
innovative assistance system and future plans
With your platform Oryom, Forslight aims to expand the surgical skills by using micror robots combined with computer vision and machine learning technologies. This solution enables surgeons to precisely navigate complex eye structures and at the same time to improve ergonomics and skill. Joseph Nathan, co -founder and Chief Medical Officer, underlines the urgency of this technology: "There are over a billion people worldwide who suffer from avoidable visual impairments" - and Forsweight would like to help improve this access, especially in populated countries such as India. A big plus of robot -based cataract operations? The procedure usually takes less than 15 minutes and requires precise handles. By using robots, surgeons can concentrate on the most critical phases of the intervention, while simpler tasks are automated. This approach minimizes the risk of complications and improves the repeatability of treatments-an important content from the latest research in the field of medical technology, such as the specialists of The first fully automatic cataract operations in humans are already planned for the end of 2025, and Forslight is in discussions with the US medicinal authority FDA for approval. A remarkable performance that is underlined by the ISO 13485: 2016 certification already acquired-an internationally recognized standard for quality management systems in medical technology. The need for innovative solutions in ophthalmology is evident: According to WHO, there are only 32 ophthalmologists worldwide and 14 cataract surgeons per million inhabitants. The pressure on the medical infrastructure is growing. This increases the need for robot -based solutions in order to face this challenge and improve patient care. At the same time, studies predict that the demand for visual applications could increase by 24% by 2035, while the number of available ophthalmologists decreases. FORSIGHT Robotics is not just another tech startup; They are pioneers in a dynamic area that has the potential to transform the life of millions. With a strong focus on research and development and vision, in cataract operations as well as other eye interventions such as glaucoma and retinal diseases, Forsbight could be the key to future treatment in ophthalmology. The plans of FORSIGHT Robotics are ambitious and progress is promising. At a time when technologies are becoming increasingly important in medicine, it is only to hope that the visionaries and experts behind ForSight are well prepared in order to have a lasting influence on the world of eye health. The future looks exciting! The challenges of ophthalmology
| Details | |
|---|---|
| Ort | Israel |
| Quellen | |